May 9, 2019
Demand for combination therapies for the treatment of respiratorydiseases on an increasing spree
Demand for combination therapies for the treatment of respiratorydiseases has been on an increasing spree
Pharmaceuticals, Biotechnology and Life Sciences
Tag: bronchodilator
November 5, 2015
Verona Pharma completes inhibitor study
Verona Pharma has completed patient enrolment for the Phase IIa dose-finding study of RPL554 in asthma and the Phase IIa combination study of RPL554 in chronic obstructive pulmonary disease (COPD), in which the drug is being administered in addition to standard of care bronchodilators.